Senti Biosciences (SNTI) Shares Outstanding (Weighted Average) (2021 - 2025)
Senti Biosciences has reported Shares Outstanding (Weighted Average) over the past 5 years, most recently at $22.5 million for Q4 2025.
- Quarterly results put Shares Outstanding (Weighted Average) at $22.5 million for Q4 2025, up 389.2% from a year ago — trailing twelve months through Dec 2025 was $22.5 million (up 389.2% YoY), and the annual figure for FY2025 was $22.5 million, up 389.2%.
- Shares Outstanding (Weighted Average) for Q4 2025 was $22.5 million at Senti Biosciences, down from $26.2 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for SNTI hit a ceiling of $44.1 million in Q1 2023 and a floor of $2.9 million in Q2 2021.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $4.6 million (2024), compared with a mean of $11.6 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): surged 1289.7% in 2023 and later tumbled 89.63% in 2024.
- Senti Biosciences' Shares Outstanding (Weighted Average) stood at $2.9 million in 2021, then soared by 796.58% to $26.1 million in 2022, then tumbled by 83.01% to $4.4 million in 2023, then grew by 3.58% to $4.6 million in 2024, then soared by 389.2% to $22.5 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $22.5 million (Q4 2025), $26.2 million (Q3 2025), and $26.1 million (Q2 2025) per Business Quant data.